| A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission JM Guralnik, EM Simonsick, L Ferrucci, RJ Glynn, LF Berkman, DG Blazer, ... Journal of gerontology 49 (2), M85-M94, 1994 | 10796 | 1994 |
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ... New England journal of medicine 359 (21), 2195-2207, 2008 | 8998 | 2008 |
| Antiinflammatory therapy with canakinumab for atherosclerotic disease PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ... New England journal of medicine 377 (12), 1119-1131, 2017 | 8748 | 2017 |
| Variable selection for propensity score models MA Brookhart, S Schneeweiss, KJ Rothman, RJ Glynn, J Avorn, T Stürmer American journal of epidemiology 163 (12), 1149-1156, 2006 | 2680 | 2006 |
| C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction PM Ridker, RJ Glynn, CH Hennekens Circulation 97 (20), 2007-2011, 1998 | 1669 | 1998 |
| Long-term persistence in use of statin therapy in elderly patients JS Benner, RJ Glynn, H Mogun, PJ Neumann, MC Weinstein, J Avorn Jama 288 (4), 455-461, 2002 | 1606 | 2002 |
| Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto, JJP Kastelein, ... The Lancet 373 (9670), 1175-1182, 2009 | 1337 | 2009 |
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1327 | 2017 |
| Low-dose methotrexate for the prevention of atherosclerotic events PM Ridker, BM Everett, A Pradhan, JG MacFadyen, DH Solomon, ... New England Journal of Medicine 380 (8), 752-762, 2019 | 1256 | 2019 |
| Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial HD Sesso, JE Buring, WG Christen, T Kurth, C Belanger, J MacFadyen, ... Jama 300 (18), 2123-2133, 2008 | 1226 | 2008 |
| Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study EW Campion, RJ Glynn, LO Delabry The American journal of medicine 82 (3), 421-426, 1987 | 1207 | 1987 |
| High-dimensional propensity score adjustment in studies of treatment effects using health care claims data S Schneeweiss, JA Rassen, RJ Glynn, J Avorn, H Mogun, MA Brookhart Epidemiology 20 (4), 512-522, 2009 | 1199 | 2009 |
| Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism PM Ridker, SZ Goldhaber, E Danielson, Y Rosenberg, CS Eby, ... New England Journal of Medicine 348 (15), 1425-1434, 2003 | 1192 | 2003 |
| Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial PM Ridker, A Pradhan, JG MacFadyen, P Libby, RJ Glynn The Lancet 380 (9841), 565-571, 2012 | 1083 | 2012 |
| Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin BF Gage, C Eby, JA Johnson, E Deych, MJ Rieder, PM Ridker, ... Clinical Pharmacology & Therapeutics 84 (3), 326-331, 2008 | 1005 | 2008 |
| A combined comorbidity score predicted mortality in elderly patients better than existing scores JJ Gagne, RJ Glynn, J Avorn, R Levin, S Schneeweiss Journal of clinical epidemiology 64 (7), 749-759, 2011 | 996 | 2011 |
| A randomized trial of rosuvastatin in the prevention of venous thromboembolism RJ Glynn, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ... New England Journal of Medicine 360 (18), 1851-1861, 2009 | 943 | 2009 |
| Reduction of bacteriuria and pyuria after ingestion of cranberry juice J Avorn, M Monane, JH Gurwitz, RJ Glynn, I Choodnovskiy, LA Lipsitz Jama 271 (10), 751-754, 1994 | 931 | 1994 |
| Increased pulse pressure and risk of heart failure in the elderly CU Chae, MA Pfeffer, RJ Glynn, GF Mitchell, JO Taylor, CH Hennekens Jama 281 (7), 634-643, 1999 | 889 | 1999 |
| Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled … PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ... The Lancet 391 (10118), 319-328, 2018 | 875 | 2018 |
